Last 12 months
Inside the activity.
0 purchase rows · 12 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 10 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 29, 2026 Filed Jul 30, 2026 20:04 UTC |
Hukkelhoven MathiasDirector
|
GrantShare Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $2.26 | $0.00 |
DisclosureSEC source: 0001178913-26-003713 · zk2635768.xml · derivative · entry 2 Hukkelhoven Mathias · CIK 0001936319 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2036-07-29 F2 · derivative.exercise_date: This option vests 25% on October 1, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| July 29, 2026 Filed Jul 30, 2026 20:04 UTC |
Hukkelhoven MathiasDirector
|
GrantOrdinary Shares | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-26-003713 · zk2635768.xml · nonDerivative · entry 1 Hukkelhoven Mathias · CIK 0001936319 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,500 F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs vest 25% on October 1, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| July 29, 2026 Filed Jul 30, 2026 20:13 UTC |
Levine ZuritSVP, Business Development
|
GrantShare Option (right to buy) · Derivative | 24,000 | $0.00 Strike: $2.26 | $0.00 |
DisclosureSEC source: 0001178913-26-003729 · zk2635776.xml · derivative · entry 2 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,000 Underlying: Ordinary Shares · 24,000 shares Expires 2036-07-29 F2 · derivative.exercise_date: This option vests 25% on September 30, 2027 and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| July 29, 2026 Filed Jul 30, 2026 20:13 UTC |
Levine ZuritSVP, Business Development
|
GrantOrdinary Shares | 18,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-26-003729 · zk2635776.xml · nonDerivative · entry 1 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,375 F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs vest 25% on September 30, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| July 29, 2026 Filed Jul 30, 2026 20:11 UTC |
Silberman DavidChief Financial Officer
|
GrantShare Option (right to buy) · Derivative | 26,000 | $0.00 Strike: $2.26 | $0.00 |
DisclosureSEC source: 0001178913-26-003727 · zk2635775.xml · derivative · entry 2 Silberman David · CIK 0001867998 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,000 Underlying: Ordinary Shares · 26,000 shares Expires 2036-07-29 F2 · derivative.exercise_date: This option vests 25% on September 30, 2027 and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| July 29, 2026 Filed Jul 30, 2026 20:11 UTC |
Silberman DavidChief Financial Officer
|
GrantOrdinary Shares | 19,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-26-003727 · zk2635775.xml · nonDerivative · entry 1 Silberman David · CIK 0001867998 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,000 F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs vest 25% on September 30, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| July 29, 2026 Filed Jul 30, 2026 20:09 UTC |
Cohen-Dayag AnatDirector
|
GrantShare Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $2.26 | $0.00 |
DisclosureSEC source: 0001178913-26-003723 · zk2635773.xml · derivative · entry 1 Cohen-Dayag Anat · CIK 0001907035 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Ordinary Shares · 100,000 shares Expires 2036-07-29 F1 · derivative.exercise_date: This option vests 25% on September 30, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| July 29, 2026 Filed Jul 30, 2026 20:10 UTC |
Ophir EranDirector · President and CEO
|
GrantShare Option (right to buy) · Derivative | 200,000 | $0.00 Strike: $2.26 | $0.00 |
DisclosureSEC source: 0001178913-26-003725 · zk2635774.xml · derivative · entry 1 Ophir Eran · CIK 0001972103 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Underlying: Ordinary Shares · 200,000 shares Expires 2036-07-29 F1 · derivative.exercise_date: This option vests 25% on September 30, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| July 29, 2026 Filed Jul 30, 2026 20:08 UTC |
Perry EranDirector
|
GrantShare Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $2.26 | $0.00 |
DisclosureSEC source: 0001178913-26-003721 · zk2635772.xml · derivative · entry 2 Perry Eran · CIK 0001976264 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2036-07-29 F2 · derivative.exercise_date: This option vests 25% on October 1, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| July 29, 2026 Filed Jul 30, 2026 20:08 UTC |
Perry EranDirector
|
GrantOrdinary Shares | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-26-003721 · zk2635772.xml · nonDerivative · entry 1 Perry Eran · CIK 0001976264 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,500 F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs vest 25% on October 1, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| July 29, 2026 Filed Jul 30, 2026 20:07 UTC |
Ferre PierreChief Operating Officer
|
GrantShare Option (right to buy) · Derivative | 70,000 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001178913-26-003719 · zk2635771.xml · derivative · entry 1 Ferre Pierre · CIK 0001972518 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,000 Underlying: Ordinary Shares · 70,000 shares Expires 2036-07-29 F1 · derivative.exercise_date: This option vests 25% on September 30, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| July 29, 2026 Filed Jul 30, 2026 20:06 UTC |
Kredo Russo SharonSVP, Research & Discovery
|
GrantShare Option (right to buy) · Derivative | 24,000 | $0.00 Strike: $2.26 | $0.00 |
DisclosureSEC source: 0001178913-26-003717 · zk2635770.xml · derivative · entry 2 Kredo Russo Sharon · CIK 0002116341 · SVP, Research & Discovery 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,000 Underlying: Ordinary Shares · 24,000 shares Expires 2036-07-29 F2 · derivative.exercise_date: This option vests 25% on September 30, 2027 and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| July 29, 2026 Filed Jul 30, 2026 20:06 UTC |
Kredo Russo SharonSVP, Research & Discovery
|
GrantOrdinary Shares | 18,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-26-003717 · zk2635770.xml · nonDerivative · entry 1 Kredo Russo Sharon · CIK 0002116341 · SVP, Research & Discovery 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,500 F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs vest 25% on September 30, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| July 29, 2026 Filed Jul 30, 2026 20:05 UTC |
Livnat Savitzky KinneretDirector
|
GrantShare Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $2.26 | $0.00 |
DisclosureSEC source: 0001178913-26-003715 · zk2635769.xml · derivative · entry 2 Livnat Savitzky Kinneret · CIK 0001972182 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2036-07-29 F2 · derivative.exercise_date: This option vests 25% on October 1, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| July 29, 2026 Filed Jul 30, 2026 20:05 UTC |
Livnat Savitzky KinneretDirector
|
GrantOrdinary Shares | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-26-003715 · zk2635769.xml · nonDerivative · entry 1 Livnat Savitzky Kinneret · CIK 0001972182 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,850 F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs vest 25% on October 1, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| July 29, 2026 Filed Jul 30, 2026 20:03 UTC |
Halevy GileadDirector
|
GrantShare Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $2.26 | $0.00 |
DisclosureSEC source: 0001178913-26-003711 · zk2635767.xml · derivative · entry 2 Halevy Gilead · CIK 0001972184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2036-07-29 F2 · derivative.exercise_date: This option vests 25% on October 1, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| July 29, 2026 Filed Jul 30, 2026 20:03 UTC |
Halevy GileadDirector
|
GrantOrdinary Shares | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-26-003711 · zk2635767.xml · nonDerivative · entry 1 Halevy Gilead · CIK 0001972184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,907 F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs vest 25% on October 1, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| July 29, 2026 Filed Jul 30, 2026 20:02 UTC |
ZWEIFACH SANFORD SDirector
|
GrantShare Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $2.26 | $0.00 |
DisclosureSEC source: 0001178913-26-003709 · zk2635766.xml · derivative · entry 2 ZWEIFACH SANFORD S · CIK 0001231269 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2036-07-29 F2 · derivative.exercise_date: This option vests 25% on October 1, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| July 29, 2026 Filed Jul 30, 2026 20:02 UTC |
ZWEIFACH SANFORD SDirector
|
GrantOrdinary Shares | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-26-003709 · zk2635766.xml · nonDerivative · entry 1 ZWEIFACH SANFORD S · CIK 0001231269 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,180 F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs vest 25% on October 1, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| July 29, 2026 Filed Jul 30, 2026 20:01 UTC |
Mahler MichelleChief Medical Officer
|
GrantShare Option (right to buy) · Derivative | 18,000 | $0.00 Strike: $2.26 | $0.00 |
DisclosureSEC source: 0001178913-26-003706 · zk2635765.xml · derivative · entry 2 Mahler Michelle · CIK 0002041318 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,000 Underlying: Ordinary Shares · 18,000 shares Expires 2036-07-29 F2 · derivative.exercise_date: This option vests 25% on September 30, 2027 and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| July 29, 2026 Filed Jul 30, 2026 20:01 UTC |
Mahler MichelleChief Medical Officer
|
GrantOrdinary Shares | 13,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-26-003706 · zk2635765.xml · nonDerivative · entry 1 Mahler Michelle · CIK 0002041318 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,625 F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs vest 25% on September 30, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| July 09, 2026 Filed Jul 13, 2026 20:01 UTC |
Levine ZuritSVP, Business Development
|
Exercise / conversionShare Option (right to buy) · Derivative | 1,875 | $0.00 Strike: $0.83 | $0.00 |
DisclosureSEC source: 0001178913-26-003472 · zk2635673.xml · derivative · entry 3 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,750 Underlying: Ordinary Shares · 1,875 shares Expires 2032-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. F2 · derivative.exercise_date: This option vested 25% on December 31, 2023 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| July 09, 2026 Filed Jul 13, 2026 20:01 UTC |
Levine ZuritSVP, Business Development
|
SaleOrdinary Shares | 1,875 | $2.50 | $4,687.50 |
DisclosureSEC source: 0001178913-26-003472 · zk2635673.xml · nonDerivative · entry 2 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,375 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. Read SEC document |
| July 09, 2026 Filed Jul 13, 2026 20:01 UTC |
Levine ZuritSVP, Business Development
|
Exercise / conversionOrdinary Shares | 1,875 | $0.83 | $1,554.75 |
DisclosureSEC source: 0001178913-26-003472 · zk2635673.xml · nonDerivative · entry 1 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. Read SEC document |
| April 24, 2026 Filed Apr 27, 2026 20:03 UTC |
Levine ZuritSVP, Business Development
|
Exercise / conversionShare Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $1.15 | $0.00 |
DisclosureSEC source: 0001178913-26-002245 · ownership.xml · derivative · entry 3 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,000 Underlying: Ordinary Shares · 2,000 shares Expires 2033-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. F2 · derivative.exercise_date: This option vested 25% on September 30, 2024 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| April 24, 2026 Filed Apr 27, 2026 20:03 UTC |
Levine ZuritSVP, Business Development
|
SaleOrdinary Shares | 2,000 | $3.20 | $6,400.00 |
DisclosureSEC source: 0001178913-26-002245 · ownership.xml · nonDerivative · entry 2 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,375 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. Read SEC document |
| April 24, 2026 Filed Apr 27, 2026 20:03 UTC |
Levine ZuritSVP, Business Development
|
Exercise / conversionOrdinary Shares | 2,000 | $1.15 | $2,300.00 |
DisclosureSEC source: 0001178913-26-002245 · ownership.xml · nonDerivative · entry 1 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,375 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. Read SEC document |
| April 24, 2026 Filed Apr 27, 2026 20:02 UTC |
Ophir EranDirector · President and CEO
|
Exercise / conversionShare Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $0.83 | $0.00 |
DisclosureSEC source: 0001178913-26-002243 · ownership.xml · derivative · entry 3 Ophir Eran · CIK 0001972103 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,375 Underlying: Ordinary Shares · 5,000 shares Expires 2032-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025. F3 · derivative.exercise_date: This option vested 25% on December 31, 2023 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| April 24, 2026 Filed Apr 27, 2026 20:02 UTC |
Ophir EranDirector · President and CEO
|
SaleOrdinary Shares | 5,000 | $3.20 | $16,000.50 |
DisclosureSEC source: 0001178913-26-002243 · ownership.xml · nonDerivative · entry 2 Ophir Eran · CIK 0001972103 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,375 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.20 to $3.205 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 24, 2026 Filed Apr 27, 2026 20:02 UTC |
Ophir EranDirector · President and CEO
|
Exercise / conversionOrdinary Shares | 5,000 | $0.83 | $4,146.00 |
DisclosureSEC source: 0001178913-26-002243 · ownership.xml · nonDerivative · entry 1 Ophir Eran · CIK 0001972103 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,375 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025. Read SEC document |
| April 14, 2026 Filed Apr 15, 2026 20:10 UTC |
Ophir EranDirector · President and CEO
|
Exercise / conversionShare Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $0.83 | $0.00 |
DisclosureSEC source: 0001178913-26-002133 · zk2635085.xml · derivative · entry 3 Ophir Eran · CIK 0001972103 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,375 Underlying: Ordinary Shares · 5,000 shares Expires 2032-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025. F3 · derivative.exercise_date: This option vested 25% on December 31, 2023 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| April 14, 2026 Filed Apr 15, 2026 20:10 UTC |
Ophir EranDirector · President and CEO
|
SaleOrdinary Shares | 5,000 | $2.90 | $14,521.00 |
DisclosureSEC source: 0001178913-26-002133 · zk2635085.xml · nonDerivative · entry 2 Ophir Eran · CIK 0001972103 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,375 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.90 to $2.91 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 14, 2026 Filed Apr 15, 2026 20:10 UTC |
Ophir EranDirector · President and CEO
|
Exercise / conversionOrdinary Shares | 5,000 | $0.83 | $4,146.00 |
DisclosureSEC source: 0001178913-26-002133 · zk2635085.xml · nonDerivative · entry 1 Ophir Eran · CIK 0001972103 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,375 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025. Read SEC document |
| April 14, 2026 Filed Apr 15, 2026 20:07 UTC |
Levine ZuritSVP, Business Development
|
Exercise / conversionShare Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $1.15 | $0.00 |
DisclosureSEC source: 0001178913-26-002131 · zk2635084.xml · derivative · entry 3 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,000 Underlying: Ordinary Shares · 2,000 shares Expires 2033-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. F2 · derivative.exercise_date: This option vested 25% on September 30, 2024 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| April 14, 2026 Filed Apr 15, 2026 20:07 UTC |
Levine ZuritSVP, Business Development
|
SaleOrdinary Shares | 2,000 | $2.80 | $5,600.00 |
DisclosureSEC source: 0001178913-26-002131 · zk2635084.xml · nonDerivative · entry 2 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,375 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. Read SEC document |
| April 14, 2026 Filed Apr 15, 2026 20:07 UTC |
Levine ZuritSVP, Business Development
|
Exercise / conversionOrdinary Shares | 2,000 | $1.15 | $2,300.00 |
DisclosureSEC source: 0001178913-26-002131 · zk2635084.xml · nonDerivative · entry 1 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,375 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. Read SEC document |
| April 10, 2026 Filed Apr 13, 2026 20:04 UTC |
Levine ZuritSVP, Business Development
|
Exercise / conversionShare Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $1.15 | $0.00 |
DisclosureSEC source: 0001178913-26-002089 · zk2635070.xml · derivative · entry 5 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,000 Underlying: Ordinary Shares · 2,000 shares Expires 2033-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. F4 · derivative.exercise_date: This option vested 25% on September 30, 2024 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| April 10, 2026 Filed Apr 13, 2026 20:04 UTC |
Levine ZuritSVP, Business Development
|
Exercise / conversionShare Option (right to buy) · Derivative | 1,125 | $0.00 Strike: $0.83 | $0.00 |
DisclosureSEC source: 0001178913-26-002089 · zk2635070.xml · derivative · entry 4 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,625 Underlying: Ordinary Shares · 1,125 shares Expires 2032-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. F3 · derivative.exercise_date: This option vested 25% on December 31, 2023 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| April 10, 2026 Filed Apr 13, 2026 20:04 UTC |
Levine ZuritSVP, Business Development
|
SaleOrdinary Shares | 3,125 | $2.56 | $8,012.50 |
DisclosureSEC source: 0001178913-26-002089 · zk2635070.xml · nonDerivative · entry 3 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,375 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.50 to $2.60 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 10, 2026 Filed Apr 13, 2026 20:04 UTC |
Levine ZuritSVP, Business Development
|
Exercise / conversionOrdinary Shares | 2,000 | $1.15 | $2,300.00 |
DisclosureSEC source: 0001178913-26-002089 · zk2635070.xml · nonDerivative · entry 2 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. Read SEC document |
| April 10, 2026 Filed Apr 13, 2026 20:04 UTC |
Levine ZuritSVP, Business Development
|
Exercise / conversionOrdinary Shares | 1,125 | $0.83 | $932.85 |
DisclosureSEC source: 0001178913-26-002089 · zk2635070.xml · nonDerivative · entry 1 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. Read SEC document |
| April 10, 2026 Filed Apr 15, 2026 20:03 UTC Amendment |
Levine ZuritSVP, Business Development
|
Exercise / conversionShare Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $1.15 | $0.00 |
DisclosureSEC source: 0001178913-26-002128 · zk2635083.xml · derivative · entry 5 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,000 Underlying: Ordinary Shares · 2,000 shares Expires 2033-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. F4 · derivative.exercise_date: This option vested 25% on September 30, 2024 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| April 10, 2026 Filed Apr 15, 2026 20:03 UTC Amendment |
Levine ZuritSVP, Business Development
|
Exercise / conversionShare Option (right to buy) · Derivative | 1,125 | $0.00 Strike: $0.83 | $0.00 |
DisclosureSEC source: 0001178913-26-002128 · zk2635083.xml · derivative · entry 4 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,625 Underlying: Ordinary Shares · 1,125 shares Expires 2032-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. F3 · derivative.exercise_date: This option vested 25% on December 31, 2023 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| April 10, 2026 Filed Apr 15, 2026 20:03 UTC Amendment |
Levine ZuritSVP, Business Development
|
SaleOrdinary Shares | 3,125 | $2.56 | $8,012.50 |
DisclosureSEC source: 0001178913-26-002128 · zk2635083.xml · nonDerivative · entry 3 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,375 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.50 to $2.60 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 10, 2026 Filed Apr 15, 2026 20:03 UTC Amendment |
Levine ZuritSVP, Business Development
|
Exercise / conversionOrdinary Shares | 2,000 | $1.15 | $2,300.00 |
DisclosureSEC source: 0001178913-26-002128 · zk2635083.xml · nonDerivative · entry 2 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. Read SEC document |
| April 10, 2026 Filed Apr 15, 2026 20:03 UTC Amendment |
Levine ZuritSVP, Business Development
|
Exercise / conversionOrdinary Shares | 1,125 | $0.83 | $932.85 |
DisclosureSEC source: 0001178913-26-002128 · zk2635083.xml · nonDerivative · entry 1 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. Read SEC document |
| April 08, 2026 Filed Apr 9, 2026 20:05 UTC |
Levine ZuritSVP, Business Development
|
Exercise / conversionShare Option (right to buy) · Derivative | 1,000 | $0.00 Strike: $1.15 | $0.00 |
DisclosureSEC source: 0001178913-26-002036 · zk2635040.xml · derivative · entry 8 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,000 Underlying: Ordinary Shares · 1,000 shares Expires 2033-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. F3 · derivative.exercise_date: This option vested 25% on September 30, 2024 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| April 08, 2026 Filed Apr 9, 2026 20:05 UTC |
Levine ZuritSVP, Business Development
|
Exercise / conversionShare Option (right to buy) · Derivative | 4,375 | $0.00 Strike: $0.83 | $0.00 |
DisclosureSEC source: 0001178913-26-002036 · zk2635040.xml · derivative · entry 7 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,750 Underlying: Ordinary Shares · 4,375 shares Expires 2032-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. F2 · derivative.exercise_date: This option vested 25% on December 31, 2023 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| April 08, 2026 Filed Apr 9, 2026 20:05 UTC |
Levine ZuritSVP, Business Development
|
SaleOrdinary Shares | 5,375 | $2.42 | $13,007.50 |
DisclosureSEC source: 0001178913-26-002036 · zk2635040.xml · nonDerivative · entry 5 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,375 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. Read SEC document |
| April 08, 2026 Filed Apr 9, 2026 20:05 UTC |
Levine ZuritSVP, Business Development
|
Exercise / conversionOrdinary Shares | 1,000 | $1.15 | $1,150.00 |
DisclosureSEC source: 0001178913-26-002036 · zk2635040.xml · nonDerivative · entry 4 Levine Zurit · CIK 0001972527 · SVP, Business Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 34,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.